Company Analysis

DataMeds AI, Inc. (MEDS)

Nasdaq: MEDS · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Tampa, FL · filing with the SEC since 2024
Grade3.1
◀ Past 2.7● Present 2.7▶ Future 4.1
4 est.

Who owns DataMeds AI, Inc.

As filed with the SEC
Holders of 5% or more
0
No Schedule 13D or 13G naming this company is on file.
Directors and officers
9
report now, of 17 people on the record since 2025. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 0 named at left.
Holders of 5% or moreshare of the class, as filed
No holder of 5% or more is on file in a Schedule 13D or 13G naming this company.
What MEDS reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Draper Inc
An entity · legal entity · owns, named in the 10-K filed Mar 20, 2026
Hudson Global Ventures LLC
An entity · legal entity · owns, named in the 10-K filed Mar 20, 2026
Integra Pharma Solutions LLC
An entity · legal entity, related party · owns, named in the 10-K filed Mar 20, 2026
Integral Health Inc
An entity · legal entity · owns, named in the 10-K filed Mar 20, 2026
SPAC Transaction
An entity · legal entity · owns, named in the 10-K filed Mar 20, 2026
Tollo Health, LLC
An entity · legal entity · owns, named in the 10-K filed Mar 20, 2026
Wellgistics LLC
A company bought · acquisition · owns, named in the 10-K filed Mar 20, 2026
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.
SI Assistanton MEDS · research, not advice